Three-medicine therapy for newly diagnosed type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new combination of three medicines to improve blood sugar control in people who are newly diagnosed with type 2 diabetes. It may help reduce blood sugar levels and support weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have type 2 diabetes that was diagnosed within the last year, or you are newly diagnosed.
- You have not taken diabetes medication regularly in the past 3 months.
- Your HbA1c (a blood sugar measure) is between 6.5% and 9.0%.
- Your BMI (body mass index) is 24 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination of three diabetes medicines for people recently diagnosed with type 2 diabetes. It aims to see if this triple therapy controls blood sugar better than the standard two-drug approach.
This study tests a combination of three diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps control blood sugar in people with type 2 diabetes. It may be an option if your current treatment isn't working well enough.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This trial tests a combination of three diabetes medicines to see if they can quickly get high blood sugar under control in people newly diagnosed with type 2 diabetes. It's designed for those whose HbA1c is 9.0% or higher.
This trial tests a combination of three diabetes medicines (henagliflozin proline, retagliptin, and metformin) for people newly diagnosed with type 2 diabetes. The goal is to see how well the combination controls blood sugar and to check its safety.
This trial tests a new combination pill that includes three medications to lower blood sugar in people with type 2 diabetes. It aims to see if this combination is safe and effective for Chinese patients.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.